News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

|Articles|July 1, 2015

Collaborative Success Strategies for Biopharm Companies

Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with BioPharm International about collaborative success strategies for biopharm companies.

Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with BioPharm International about collaborative success strategies for biopharm companies.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization

ByFeliza Mirasol

October 31st 2025

BioPharma By The Numbers

BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints

October 31st 2025

BioPharm Weekly News Roundup—Week of Oct. 27, 2025

ByFeliza Mirasol

October 31st 2025

small interfering RNA bound to a messenger RNA, cartoon model with semi-transparent surface. siRNAs are synthetic RNA interference tools used for inducing temporary reduction of mRNA expression. | Image credit: © petarg - © petarg - stock.adobe.com

How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain

ByFeliza Mirasol

October 30th 2025

RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback

ByPatrick Lavery

October 30th 2025

Trending on BioPharm International

How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain

Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization

BioPharm Weekly News Roundup—Week of Oct. 27, 2025

How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?

BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints

© 2025 MJH Life Sciences^®

All rights reserved.